Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.

Sao Paulo medical journal = Revista paulista de medicina - 3 Nov 2005

Couto Egle, Nomura Marcelo Luís, Barini Ricardo, Pinto e Silva João Luiz

Abstract excerpt

CONTEXT: Pregnancy and puerperium raise the risk of thromboembolic events, and these risks are increased in women who are carriers of thrombophilia factors. Prothrombin (FII) G20210A and factor V Leiden heterozygous mutations are associated with moderate risk of thrombosis. The association of these thrombophilic conditions is very rare in pregnancy, and the real risk of thrombosis is unknown. CASE REPORT: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Heparin

Share to Pregnancy Complications, Hematologic

Share to Prothrombin

Share to Thromboembolism

Share to Thrombophilia

Source

Open in PubMed Open full text

Identifiers

PMID: 16444389
DOI: 10.1590/s1516-31802005000600007
PMCID: PMC11060344

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.PMID 16444389Read ↗

Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.Semantic proximity Read ↗

Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.Semantic proximity Read ↗

[Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].Semantic proximity Read ↗

Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy.Semantic proximity Read ↗

Pregnancy-associated thrombosis.Semantic proximity Read ↗

[Pregnancy-associated venous thromboembolic disease: prediction, prevention, and therapy].Semantic proximity Read ↗

Thrombophilia in pregnancy: Table 1Semantic proximity Read ↗

Prothrombin 20210 G-->A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy.Semantic proximity Read ↗

Management of inherited thrombophilia in pregnancy.Semantic proximity Read ↗

Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.Semantic proximity Read ↗

Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.